Ocimum Biosolutions sets up its German Subsidiary
Ocimum Biosolutions announced today that it has set up its German subsidiary in Ebersberg (Germany) in order to expand its presence in the European market. This is a key milestone for Ocimum after its successful acquisition of the Microarrays division of MWG Biotech AG. The German subsidiary, Ocimum Germany GmbH, aims to tap the huge genomics market in Europe and provide quality R&D enabling solutions to universities, research institutes, biotech and pharma companies in Europe.
In a statement, Ms. Anuradha Acharya, CEO, Ocimum, said, “Eupore is a big market for us. We chose to base our European operations in Germany as it is centrally located in Europe.”
“This is one more consequent step in Ocimum´s overall strategy and a clear commitment to our customers”, Ludwig Winzer, Managing Director of the Ocimum Germany GmbH added.
Ocimum Biosolutions is a Hyderabad based life sciences R&D enabling company with competencies in Bioinformatics, LIMS, Microarrays, Oligonucleotide and Contract Research services. Ocimum’s innovative products have won laurels from various prestigious institutions. Ocimum emerged as the winner of NASSCOM IT Innovation in India 2005 Award for its innovative ideas and products. Deloitte Technology Fast 50 India 2005 Program, which honours the fast-growing technology companies, ranked Ocimum 4th among the 50 fast-growing technology companies in India. Ocimum was also ranked 55th among the 500 fast-growing technology companies in the Asia Pacific region in Deloitte Technology Fast 500 Asia Pacific 2005 Program. Red Herring recently listed Ocimum as one of the 8 Indian startups to watch for.
Presently, Ocimum is planning to expand further in the market through acquisitions.
